Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Robert W. DeSimone is active.

Publication


Featured researches published by Robert W. DeSimone.


Tetrahedron Letters | 1989

Total synthesis of (+)- and (−)-norsecurinine

Peter A. Jacobi; Charles A. Blum; Robert W. DeSimone; Uko E. Udodong

Abstract (−)-Norsecurinine ( 1a ) has been prepared in a stereospecific fashion beginning with the acetylenic oxazole 18 . Diels-Alder cyclization of 18 afforded the furanoketone 19 , which was transformed in five steps to the butenolide mesylate 24 . Transannular alkylation of 24 then afforded 1a . In identical fashion, ent- 18 gave (+)-norsecurinine ( 1b ).


Bioorganic & Medicinal Chemistry Letters | 2009

Imidazo[1,2-a]pyrazine diaryl ureas: Inhibitors of the receptor tyrosine kinase EphB4

Scott Mitchell; Mihaela Diana Danca; Peter Blomgren; James W. Darrow; Kevin S. Currie; Jeffrey E. Kropf; Seung Ho Lee; Steven L. Gallion; Jin-Ming Xiong; Douglas A. Pippin; Robert W. DeSimone; David R. Brittelli; David C. Eustice; Aaron Bourret; Melissa Hill-Drzewi; Patricia Maciejewski; Lisa Elkin

Inhibition of receptor tyrosine kinases (RTKs) such as vascular endothelial growth factor receptors (VEGFRs) and platelet-derived growth factor receptors (PDGFRs) has been validated by recently launched small molecules Sutent and Nexavar, both of which display activities against several angiogenesis-related RTKs. EphB4, a receptor tyrosine kinase (RTK) involved in the processes of embryogenesis and angiogenesis, has been shown to be aberrantly up regulated in many cancer types such as breast, lung, bladder and prostate. We propose that inhibition of EphB4 in addition to other validated RTKs would enhance the anti-angiogenic effect and ultimately result in more pronounced anti-cancer efficacy. Herein we report the discovery and SAR of a novel series of imidazo[1,2-a]pyrazine diarylureas that show nanomolar potency for the EphB4 receptor, in addition to potent activity against several other RTKs.


Tetrahedron Letters | 1992

Tetrapyrroles. V. Formal syntheses of the ring-C,D pyrromethenones of phytochrome and phycocyanin

Peter A. Jacobi; Robert W. DeSimone

Abstract Formal syntheses of pyrromethenones 2 and 3 , potential intermediates for the preparation of phycocyanin ( 5 ) and phytochrome ( 4 ), respectively, have been accomplished by Pd o mediated coupling of iodopyrrole 7 with acetylenic amides of general structure 8a,b followed by F- catalyzed 5-exo-dig cyclization and DDQ oxidation.


Bioorganic & Medicinal Chemistry Letters | 2000

Substituted 3-(2-benzoxazyl)-benzimidazol-2-(1H)-ones : A new class of GABAA brain receptor ligands

Robert W. DeSimone; Charles A. Blum

A novel class of potent benzodiazepine receptor (BZR) ligands has been designed and synthesized aided by molecular modeling of known benzodiazepine ligands such as CGS-8216 and the use of known pharmacophore models.


Archive | 2001

Capsaicin receptor ligands

Rajagopal Bakthavatchalam; Alan Hutchison; Robert W. DeSimone; Keven J. Hodgetts; James E. Krause; Geoffrey White


Archive | 2003

IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF

Kevin S. Currie; Robert W. DeSimone; Douglas A. Pippin; James W. Darrow; Scott A. Mitchell


Archive | 2004

Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of bruton's tyrosine kinase by such compounds

Kevin S. Currie; Robert W. DeSimone; Scott A. Mitchell; Douglas A. Pippin; James W. Darrow; Xiaobing Qian; Mark Velleca; Dapeng Qian


Archive | 2004

Certain heterocyclic substituted imidazo[1,2-a]pyrazin-8-ylamines and methods of inhibition of bruton’s tyrosine kinase by such compounds

Kevin S. Currie; Robert W. DeSimone; Scott A. Mitchell; Douglas A. Pippin


Archive | 2004

Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity

Scott A. Mitchell; Kevin S. Currie; Robert W. DeSimone; Douglas A. Pippin


Archive | 2004

Imidazo[1,2-a] pyrazin-8-ylamines as kinase inhibitors

Kevin S. Currie; Robert W. DeSimone; Douglas A. Pippin; James W. Darrow; Scott A. Mitchell

Collaboration


Dive into the Robert W. DeSimone's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Geoffrey White

Washington University in St. Louis

View shared research outputs
Researchain Logo
Decentralizing Knowledge